Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 6, 2003, Pages 1952-1957

  Sihvo, Eero I T ^a   Ruohtula, Terhi ^b   Auvinen, Merja I ^b   Koivistoinen, Aki ^b   Harjula, Ari L ^a   Salo, Jarmo A ^a   Mentzer, Steven J ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT;

ADULT; ANGIOGENESIS; ARTICLE; BARRETT ESOPHAGUS; CELL PROLIFERATION; CYTOARCHITECTURE; DNA ADDUCT; DNA CONTENT; ENZYME ACTIVITY; ESOPHAGUS MUCOSA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; TISSUE SECTION;

EID: 0345802939     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.08.014     Document Type: Article

References (41)

1. Lagergren J, Bergström R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825-31.
2. Blot WJ, Deveasa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287-9.
3. Sihvo EIT, Salminen JT, Rämö OJ, Salo JA. The epidemiology of oesophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma? Scand J Gastroenterol. 2000;35:1082-6.
4. Levine DS. Management of dysplasia in the columnar-lined esophagus. Gastroenterol Clin North Am. 1997;26:613-34.
5. Chen X, Yang CY. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis. 2001;22:1119-29.
6. Farhadi A, Fields J, Banan A, Keshavarzian A. Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett's esophagus, and the latter's progression toward esophageal cancer? Am J Gastroenterol. 2002;97:22-6.
7. Yasuda M, Ohzeki Y, Shimizu S, Naito S, Ohtsuru A, Yamamoto T, et al. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci. 1999;64:249-58.
8. Ezaki T, Baluk P, Thurston G, La Barbara A, Woo C, McDonald DM. Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. Am J Pathol. 2001;158:2043-55.
9. Collins RH, Feldman M, Fordtran JS. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis: a critical review. N Engl J Med. 1987;316:1654-8.
10. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, et al. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res. 1994;54:3171-2.
11. Holzinger F, Z'graggen K, Büchler MW. Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma. Ann Oncol. 1999;10(suppl 4):S 122-6.
12. Carmeliet P, Jain R. Angiogenesis in cancer and other diseases. Nature. 2000;407:249-57.
13. Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res. 2000;60:6298-302.
14. Soslow RA, Ying L, Altorki NK. Expression of acidic fibroblast growth factor in Barrett's esophagus and associated esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 1997;114:838-43.
15. Couvelard A, Paraf F, Gratio V, Scoazec JY, Henin D, Degott C, et al. Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression. J Pathol. 2000;192:14-8.
16. Millikan KW, Mall JW, Myers JA, Hollinger EF, Doolas A, Saclarides TJ. Do angiogenesis and growth factor expression predict prognosis of esophageal cancer? Am Surg. 2000;66:401-5.
17. Schwartz JL, Shklar G. Glutathione inhibits experimental oral carcinogenesis, p53 expression, and angiogenesis. Nutr Cancer. 1996;26:229-36.
18. Marikovsky M, Nevo N, Vadai E, Harris-Cerruti C. Cu/Zn superoxide dismutase plays a role in angiogenesis. Int J Cancer. 2002;97:34-41.
19. Ogino K, Oka S, Okazaki Y, Takemoto T. Gastric mucosal protection and superoxide dismutase. J Clin Gastroenterol. 1988;10(suppl 1): S129-32.
20. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res. 1999;31:273-300.
21. Peters WHM, Roelofs HMJ, Hectors MPC, Nagengast FM, Jansen JB. Glutathione and glutathione S-transferases in Barrett's epithelium. Br J Cancer. 1993;67:1413-7.
22. Wetscher GJ, Hinder RA, Bagchi D, Hinder PR, Bagchi M, Perdikis G, et al. Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg. 1995;170:552-6.
23. Olyaee M, Sontag S, Salman W, Schnell T, Mobarhan S, Eiznhamer D, et al. Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus. Gut. 1995;37:168-73.
24. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem. 1983;132:345-52.
25. Laihia JK, Jansen CT, Ahotupa M. Lucigenin and linoleate enhanced chemiluminescent assay for superoxide dismutase activity. Free Radic Biol Med. 1993;14:457-61.
26. Saville B. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst. 1985;83:670-2.
27. Gupta RC. Non-random binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci U S A. 1984;81:6943-7.
28. Ryan HE, Lo J, Johnsson RS. HIF-alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 1998;17:3005-15.
29. Oh TY, Lee JS, Ahn BO, Cho H, Kim WB, Kim YB, et al. Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment. Free Radic Biol Med. 2001;30:905-15.
30. Terry P, Lagergren J, Ye W, Nyren O, Wolk A. Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer. 2000;87:750-4.
31. Torres C, Turner JR, Wang HH, Richards W, Sugarbaker D, Shahsafaei A, et al. Pathologic prognostic factors in Barrett's-associated adenocarcinoma: a follow-up study of 96 patients. Cancer. 1999;85:520-8.
32. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 1991;64:327-36.
33. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-64.
34. Maulik N, Das DK. Redox signaling in vascular angiogenesis. Free Radic Biol Med. 2002;33:1047-60.
35. Triadafilopoulo G, Kumble S. Transforming growth factor beta one (TGFbl) expression is enhanced in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma [abstract]. Gastroenterology. 1996;110:A1126.
36. Salmela MT, Karjalainen-Lindsber ML, Puolakkainen P, Saarialho-Kere U. Upregulation and differential expression of matrilysin (MM-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma. Br J Surg. 2001;85:383-92.
37. Wang M, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, Abbruzzese MC, et al. DNA adducts in human pancreatic tissues and their potential role in carcinogenesis. Cancer Res. 1998;58:38-41.
38. Schmid K, Nair J, Winde G, Velic I, Bartsch H. Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients. Int J Cancer. 2000;87:1-4.
39. Harris CA, Derbin KS, Hunte-McDonough B, Krauss MR, Chen KT, Smith DM, et al. Manganese superoxide dismutase is induced by IFN-γ in multiple cell lines. Synergistic induction by IFN-γ tumor necrosis factor or IL-1. J Immunol. 1991;147:149-54.
40. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer. 1996;32A:30-8.
41. Janssen AM, Bosman CB, van Duijn W, Oostendorp-van de Ruit MM, Kubben FJ, Griffioen G, et al. Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Clin Cancer Res. 2000;6:3183-92.